Fidel at the 17th Annual Clinical Trials Summit 2026
12/06/2026
Fidel participated in the 17th Annual Clinical Trials Summit 2026, held from 10–11 June 2026 in Mumbai, bringing together leaders, innovators, researchers, and decision-makers from across the pharmaceutical, healthcare, and clinical research industries
Representing Fidel at the event was Mayur Gadekar, Marketing Manager, who engaged with industry experts, technology leaders, and healthcare professionals in meaningful discussions around the evolving landscape of clinical research, healthcare technology, and multilingual communication.
The summit featured insightful sessions and panel discussions covering a wide range of industry-critical topics, including decentralized clinical trials (DCT), patient safety and patient-centric research approaches, adaptive clinical trial design, regulatory compliance, digital transformation in healthcare, AI-driven innovations, and the advancement of India’s clinical trials ecosystem.
Throughout the event, Fidel connected with CEOs, founders, directors, global healthcare leaders, medical affairs professionals, medical safety experts, and clinical research specialists from leading organizations. These interactions provided valuable opportunities to exchange perspectives on emerging industry trends and explore potential collaboration opportunities.
Fidel is a trusted provider of localization, translation and technology solutions, helping organizations communicate effectively across languages and global markets. With extensive experience in the Healthcare and Life Sciences sector, Fidel offers specialized services including multilingual localization, linguistic validation, medical translation, software and website localization, and AI-powered language solutions. Through Linguify, its no-code multilingual enablement platform, along with custom healthcare technology and software development services, Fidel helps organizations enhance global patient engagement, improve regulatory compliance, and accelerate international business growth.
A key theme that emerged across discussions was the growing need for multilingual communication and localization in global clinical studies. As clinical trials continue to expand across geographies, organizations are increasingly seeking solutions that support accurate, compliant, and culturally relevant communication with patients, healthcare professionals, and regulatory stakeholders.
The summit also highlighted the rapid adoption of AI-powered technologies, digital platforms, and decentralized trial models, creating new opportunities for innovation across the healthcare and life sciences sectors. These industry developments align closely with Fidel’s capabilities in Localization Services, Linguify, Healthcare Technology Solutions, Software Development Services and Japan Bridge initiatives.
Fidel looks forward to building on the relationships established during the summit and continuing to support healthcare and life sciences organizations with innovative localization and technology solutions that help accelerate global research and patient engagement.
To connect with Fidel or to know about our multilingual healthcare capabilities please get in touch with us at: sales@fidelsoftech.com.
Ref. No – FN06261171